Literature DB >> 7056272

Quinidine-digoxin interaction: evidence for involvement of an extrarenal mechanism.

W Doering, B Fichtl, M Herrmann, E Besenfelder.   

Abstract

The influence of quinidine 750mg per day for one week on serum digoxin concentration (SDC) was evaluated in digitalized anuric patients on chronic haemodialysis. During quinidine administration the SDC increased markedly, from 0.84 +/- 0.37 to 1.58 +/- 0.72 ng/ml (p less than 0.01), a comparable effect ot that reported previously in patients with normal renal function. Neither in vitro nor in vivo did quinidine alter the serum protein binding of digoxin. The increase in SDC in anuric patients indicates a decrease in the extrarenal clearance of digoxin, which means that mechanisms other than of renal origin are also involved in the interaction of quinidine and digoxin. There was great interindividual variability in the extent of the quinidine-induced rise in SDC. Regardless of the state of renal function, careful monitoring of digitalized patients seems mandatory once quinidine treatment is initiated.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7056272     DOI: 10.1007/bf00637614

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE.

Authors:  J E DOHERTY; W H PERKINS; M C WILSON
Journal:  Am J Med       Date:  1964-10       Impact factor: 4.965

2.  Effect of quinidine on plasma concentrations of digoxin.

Authors:  G Ejvinsson
Journal:  Br Med J       Date:  1978-02-04

3.  Effect of quinidine on plasma concentration and renal clearance of digoxin. A clinically important drug interaction.

Authors:  R Dahlqvist; G Ejvinsson; K Schenck-Gustafsson
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

4.  [Interaction of quinidine and digoxin in humans (author's transl)].

Authors:  T Risler; U Peters; B Grabensee; L Seipel
Journal:  Dtsch Med Wochenschr       Date:  1979-10-26       Impact factor: 0.628

Review 5.  Clinical pharmacokinetics of digoxin.

Authors:  E Iisalo
Journal:  Clin Pharmacokinet       Date:  1977 Jan-Feb       Impact factor: 6.447

6.  Quinidine-digoxin interaction: effect of quinidine on 86Rb-uptake of human erythrocytes.

Authors:  W Doering; G G Belz
Journal:  Klin Wochenschr       Date:  1981-01-15

7.  Enhanced cardiac effect of digoxin during quinidine treatment.

Authors:  E B Leahey; J A Reiffel; R H Heissenbuttel; R E Drusin; W P Lovejoy; J T Bigger
Journal:  Arch Intern Med       Date:  1979-05

8.  [The influence of quinidine on serum digoxin concentrations (author's transl)].

Authors:  W Doering; E König
Journal:  Med Klin       Date:  1978-07-28

9.  Interaction between quinidine and digoxin.

Authors:  E B Leahey; J A Reiffel; R E Drusin; R H Heissenbuttel; W P Lovejoy; J T Bigger
Journal:  JAMA       Date:  1978-08-11       Impact factor: 56.272

10.  The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study.

Authors:  E B Leahey; J A Reiffel; E G Giardina; J T Bigger
Journal:  Ann Intern Med       Date:  1980-05       Impact factor: 25.391

View more
  7 in total

Review 1.  Pharmacokinetic interactions with digoxin.

Authors:  S M Rodin; B F Johnson
Journal:  Clin Pharmacokinet       Date:  1988-10       Impact factor: 6.447

Review 2.  Pharmacokinetic drug interactions between digoxin and antiarrhythmic agents and calcium channel blocking agents: an appraisal of study methodology.

Authors:  E M Antman; J M Arnold; P L Friedman; T W Smith
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

3.  Influence of quinidine on the binding of [3H]-ouabain and [3H]-digoxin by human lymphocytes.

Authors:  K E Pedersen; N A Klitgaard
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 4.  The quinidine-digoxin interaction in perspective.

Authors:  B Fichtl; W Doering
Journal:  Clin Pharmacokinet       Date:  1983 Mar-Apr       Impact factor: 6.447

Review 5.  Differential pharmacokinetics of digoxin in elderly patients.

Authors:  C G Hanratty; P McGlinchey; G D Johnston; A P Passmore
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

6.  Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling.

Authors:  P J Williams; J Lane; W Murray; M A Mergener; M Kamigaki
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

7.  Effect of coadministration of verapamil and quinidine on serum digoxin concentration.

Authors:  W Doering
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.